Company / SG&A per Share
RHYTHM PHARMACEUTICALS, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.12
FY2025
5-year range
$1.38 / $3.12
FY2021-FY2025
Trend
+28.7%
vs FY2024
Sector context
#62 of 210
Health Care
What the data says
At $3.12, RHYTHM PHARMACEUTICALS, INC.'s sg&a per share ranks #149 of 210 in the Health Care sector. SG&A per Share has increased for 6 consecutive years, from $1.00 in FY2019 to $3.12 in FY2025.
Based on SEC 10-K filings.
3.12 in FY2025 with a 5-year CAGR of +24.5%.
Increased from $2.08 to $3.12 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +21.0%
- 5-Year CAGR
- +24.5%
- 10-Year CAGR
- -
Sector benchmark
#149 of 210 in Health CareTop 70% of 210This company $3.12 Sector average $40.75
▼
-92.3% below sector average
Key checks
Key Insights
- RHYTHM PHARMACEUTICALS, INC.'s sg&a per share has grown for 6 consecutive years.
- In FY2025, sg&a per share increased 28.7% year-over-year.
- Ranks #62 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.12 | +28.7% |
| FY2024 | $2.43 | +17.0% |
| FY2023 | $2.08 | +17.6% |
| FY2022 | $1.77 | +27.9% |
| FY2021 | $1.38 | +32.1% |
| FY2020 | $1.05 | +4.2% |
| FY2019 | $1.00 | -2.5% |
| FY2018 | $1.03 | +10.3% |
| FY2017 | $0.93 | +50.8% |
| FY2016 | $0.62 | +84.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026